Leadership Opportunities 2022
The nominations committee is now inviting expressions of interest from all Society members in good standing for the following positions
3x Governors (2023 - 2025)
The nominations committee is now inviting expressions of interest from all Society members in good standing for the following positions
3x Governors (2023 - 2025)
Advancing beyond growing and testing individual cell lines in the lab, UF Health scientists have discovered a novel method of cryopreserving lung tissue at -184°F with the intention of studying the impact of the coronavirus and COVID-19 on the tissue. A key ingredient in this new cryopreserving method is a protein found in Antarctic fish which inhibits the formation of ice crystals. “When we thaw these lung tissue cells, they retain many of the original properties from before they were frozen,” said Matthew Schaller, Ph.D., an assistant professor in the UF College of Medicine’s division of pulmonary, critical care and sleep medicine. “The cells are still alive and metabolically active, so they can eat and secrete and, importantly, be infected by virus.”
A world without your favorite wine? At best you'll pay more; at worst you won't get it at all. Climate change and a lack of biodiversity are making some grape and wine varieties obsolete. The French National Institute for Research into Agriculture, Food, and the Environment (INRAE) has launched the cryopreservation of the world's largest collection of historical grapevines. This $12.1 million (€ 10.4 million) conservation center was built to protect and support plant tissue supplied by Domaine de Vassal, a 27-hectare vineyard, with grapevines collected from the 1870s and will be stored in cryobanks of liquid nitrogen at -196°C. INRAE researcher, Phillippe Chatelet says the primary challenge will be the safe regeneration of these vine tissues.
Read more.
I pleased to announce the new Editor-in-Chief of Cryobiology has been named as Prof. Janet A.W. Elliott. Prof. Elliott will assume the role of Editor-in-Chief on January 1, 2022.
After a 12-year tenure Prof. David Rawson recently made the decision to step down as Editor-in-Chief to enjoy a (second!) retirement, but also as he believes the role of Editor-in-Chief will be better served by someone who is still active in research.
Patients in the UK will now have more time to decide their family planning after government changes the egg, sperm, and embryo storage regulations. Presently fertility storage is limited based on medical needs and limited to a 10 year period. After the successful campaign by the Progress Educational Trust, the new regulations will open fertility storage to more people who choose fertility storage for medical or social reasons and provide a 10-year renewable storage cycle for a maximum of 55 years. Fertility advances mean human eggs can be stored indefinitely without deterioration using vitrification, making the current 10-year limit obsolete. Additional conditions surrounding third-party donors and posthumous use will be investigated and regulated separately.
Please join us in welcoming Dr. Nucharin Songsasen and Dr. Kelvin Brockbank as our new Associate Editors for Cryobiology. Alongside Barbara Reed and Wim Wolkers, this brings the total number of Associate Editors to four.
Dr. Nucharin Songsasen joined the Smithsonian Conservation Biology Institute (SCBI) in 2002. She has led the Global Canid Conservation program within SCBI since 2002, expanding the program's efforts from the laboratory to field conservation in countries such as Brazil, Thailand, and Myanmar. Her laboratory focuses on developing technologies to grow ovarian follicles from domestic dogs and cats in vitro as models for preserving genetics from wild canids and felids. In December 2018 Dr. Songsasen became the head of the Center for Species Survival within SCBI. Dr. Songsasen has been a member of the Cryobiology editorial board since 2012. | ||
Dr. Kelvin Brockbank is the Founder and CEO of Tissue Testing Technologies, Research Professor of Bioengineering at Clemson University, and Adjunct Professor of Regenerative Medicine and Cell Biology at the Medical University of South Carolina. His research interests include cell, tissue and organ cryopreservation for test systems and transplantation and manufacturing methods for cell-based tissue engineered therapy products. Dr. Brockbank has been a member of the Cryobiology editorial board since 2016. |
The Society for Cryobiology 2021 election will be held October 11 - 25, 2021. The following candidates are standing for election:
Scientists at UC Santa Barbara, University of Southern California (USC), and the biotechnology company Regenerative Patch Technologies LLC (RPT) have discovered a new method for preserving RPT's stem cell-based therapy for age-related macular degeneration (AMD), the leading cause of blindness in aging populations. This new research uses a flexible scaffold, about 18 mm2, to optimize the cryopreservation of a single layer of ocular cells generated from human embryonic stem cells. Currently in clinical trials, this implant can be frozen, stored for long periods, distributed to clinical sites, then thawed and immediately implanted into the patient's eyes. The extended shelf-life and on-demand distribution will increase the number of patients who can benefit from this treatment. Read the full article.
Back from the dead... Bdelloid Rotifers are multicellular microscopic animals with a wheel-like ring of tiny hairs that circle their mouths and that live in freshwater environments. They've been around for about 50 million years. Now, scientists from the Institute of Physicochemical and Biological Problems in Soil Science in Pushchino, Russia have resuscitated rotifers that froze in ancient Siberian permafrost during the latter part of the Pleistocene epoch (2.6 million to about 11,700 years ago). These researchers drilled to 11.5 feet (3.5 meters) below the Siberia Alazeya River surface to collect their samples. The soil was radiocarbon dated at ~24,000 years old. Once thawed in the lab, these "zombie" rotifers reanimated and began reproducing asexually through parthenogenesis and created clones that were their genetic duplicates. Read the full new article...
A research team from Huazhong University of Science and Technology and Wuhan Union Hospital have developed a new medium, named Cryogel, to reverse osteoarthritis in mice with slow releasing stem cells. This sponge-like material is created at subzero temperatures and is extremely porous. After seeded the Cryogel with mesenchymal stem cells (MSCs), it is implanted at the affected joint. "It takes about two weeks for half of the implanted cells to leave, but their regenerative effects stick around for longer," said corresponding author Wei Tong from the Department of Orthopedics of Union Hospital. "So it is possible that the therapeutic result comes indirectly, via the stem cells secreting epidermal growth factors, which stimulate cell proliferation and healing, rather than directly becoming newly formed cartilage in the joint." The team also reports that this technique reduces the required stem cell amount by 90%. Read the news article or the original abstract published in Chemical Engineering Journal.